Eyevance announced the launch of Zerviate™ (cetirizine ophthalmic solution) 0.24% for the treatment of ocular itching associated with allergic conjunctivitis in patients 2 years of age and older.
The American College of Allergy, Asthma and Immunology (ACAAI) has issued a statement regarding the use of corticosteroids for patients with allergies and asthma.
Possible device malfunctions and use errors may delay or prevent treatment with EpiPen (epinephrine 0.3mg) and EpiPen Jr (epinephrine 0.15mg) autoinjectors, as well as the authorized generic versions.
Aimmune announced that the first US patients are being treated with Palforzia™ (Peanut [Arachis hypogaea] Allergen Powder-dnfp), an oral immunotherapy for peanut allergy.
FEV1 increased in patients with aspirin-tolerant asthma while on standard asthma treatment but declined in patients with aspirin-exacerbated respiratory disease.
Researchers evaluated the efficacy of dupilumab for chronic rhinosinusitis with nasal polyposis in aspirin-exacerbated respiratory disease.
Treatment with 300 mg lanadelumab every 2 weeks significantly reduced monthly hereditary angioedema attack rates compared with the 3-month historic baseline.
Children with asthma and atopic dermatitis experience worse sleep and lung function outcomes compared with children with asthma alone.
Prenatal exposure to calcium carbonate antacids was associated with the development of food protein-induced allergic proctocolitis, a type of delayed inflammatory gut food allergy to protein, in offspring.
Exposure to several antibiotics during pregnancy may be linked to the development of atopic dermatitis in offspring within the first 24 months of life.
